BLRX
Price
$3.33
Change
+$0.13 (+4.06%)
Updated
Dec 3, 04:55 PM (EDT)
Capitalization
14.43M
Intraday BUY SELL Signals
MRKR
Price
$1.26
Change
+$0.07 (+5.88%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
19.9M
Intraday BUY SELL Signals
Interact to see
Advertisement

BLRX vs MRKR

Header iconBLRX vs MRKR Comparison
Open Charts BLRX vs MRKRBanner chart's image
BioLineRx
Price$3.33
Change+$0.13 (+4.06%)
Volume$100
Capitalization14.43M
Marker Therapeutics
Price$1.26
Change+$0.07 (+5.88%)
Volume$1.4K
Capitalization19.9M
BLRX vs MRKR Comparison Chart in %
BLRX
Daily Signal:
Gain/Loss:
MRKR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BLRX vs. MRKR commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLRX is a Buy and MRKR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (BLRX: $3.19 vs. MRKR: $1.19)
Brand notoriety: BLRX and MRKR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLRX: 36% vs. MRKR: 51%
Market capitalization -- BLRX: $14.43M vs. MRKR: $19.9M
BLRX [@Biotechnology] is valued at $14.43M. MRKR’s [@Biotechnology] market capitalization is $19.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLRX’s FA Score shows that 1 FA rating(s) are green whileMRKR’s FA Score has 1 green FA rating(s).

  • BLRX’s FA Score: 1 green, 4 red.
  • MRKR’s FA Score: 1 green, 4 red.
According to our system of comparison, MRKR is a better buy in the long-term than BLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLRX’s TA Score shows that 6 TA indicator(s) are bullish while MRKR’s TA Score has 5 bullish TA indicator(s).

  • BLRX’s TA Score: 6 bullish, 3 bearish.
  • MRKR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BLRX is a better buy in the short-term than MRKR.

Price Growth

BLRX (@Biotechnology) experienced а -10.14% price change this week, while MRKR (@Biotechnology) price change was +8.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRKR($19.9M) has a higher market cap than BLRX($14.4M). MRKR (-61.736) and BLRX (-62.734) have similar YTD gains . BLRX has higher annual earnings (EBITDA): 1.97M vs. MRKR (-8.09M). BLRX has more cash in the bank: 28.2M vs. MRKR (10.5M). MRKR has less debt than BLRX: MRKR (0) vs BLRX (12.6M). BLRX has higher revenues than MRKR: BLRX (17.3M) vs MRKR (6.59M).
BLRXMRKRBLRX / MRKR
Capitalization14.4M19.9M72%
EBITDA1.97M-8.09M-24%
Gain YTD-62.734-61.736102%
P/E RatioN/AN/A-
Revenue17.3M6.59M262%
Total Cash28.2M10.5M269%
Total Debt12.6M0-
FUNDAMENTALS RATINGS
BLRX vs MRKR: Fundamental Ratings
BLRX
MRKR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
12
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
8347
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BLRX's Valuation (11) in the Pharmaceuticals Other industry is in the same range as MRKR (12) in the Other Consumer Services industry. This means that BLRX’s stock grew similarly to MRKR’s over the last 12 months.

BLRX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as MRKR (100) in the Other Consumer Services industry. This means that BLRX’s stock grew similarly to MRKR’s over the last 12 months.

BLRX's SMR Rating (97) in the Pharmaceuticals Other industry is in the same range as MRKR (99) in the Other Consumer Services industry. This means that BLRX’s stock grew similarly to MRKR’s over the last 12 months.

MRKR's Price Growth Rating (47) in the Other Consumer Services industry is somewhat better than the same rating for BLRX (83) in the Pharmaceuticals Other industry. This means that MRKR’s stock grew somewhat faster than BLRX’s over the last 12 months.

MRKR's P/E Growth Rating (100) in the Other Consumer Services industry is in the same range as BLRX (100) in the Pharmaceuticals Other industry. This means that MRKR’s stock grew similarly to BLRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLRXMRKR
RSI
ODDS (%)
Bullish Trend 6 days ago
83%
Bearish Trend 6 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
77%
Bearish Trend 6 days ago
90%
Momentum
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 6 days ago
81%
MACD
ODDS (%)
Bullish Trend 6 days ago
89%
Bullish Trend 6 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 6 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
89%
Bullish Trend 6 days ago
84%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 20 days ago
90%
Bearish Trend 27 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
83%
Bearish Trend 6 days ago
89%
Aroon
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 6 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BLRX
Daily Signal:
Gain/Loss:
MRKR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRGO3.080.06
+1.99%
Freightos Limited
ODC54.050.50
+0.93%
Oil-Dri Corporation Of America
VRSK224.980.97
+0.43%
Verisk Analytics
AIRI2.90-0.02
-0.68%
Air Industries Group
HNGE46.53-1.43
-2.98%
Hinge Health Inc.

BLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLRX has been loosely correlated with PYXS. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if BLRX jumps, then PYXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLRX
1D Price
Change %
BLRX100%
-4.49%
PYXS - BLRX
37%
Loosely correlated
-10.71%
KURA - BLRX
34%
Loosely correlated
-2.53%
DWTX - BLRX
33%
Loosely correlated
-2.05%
AEON - BLRX
32%
Poorly correlated
+1.75%
MRKR - BLRX
30%
Poorly correlated
+0.85%
More

MRKR and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRKR has been loosely correlated with NAGE. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if MRKR jumps, then NAGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRKR
1D Price
Change %
MRKR100%
+0.85%
NAGE - MRKR
33%
Loosely correlated
-4.12%
XNCR - MRKR
32%
Poorly correlated
-3.15%
BLRX - MRKR
32%
Poorly correlated
-4.49%
CDXS - MRKR
32%
Poorly correlated
-0.30%
OSTX - MRKR
31%
Poorly correlated
-2.75%
More